BioSpace News Archive

Business

Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2019 Financial Results

Company Advancing ALPN-101 into a Phase 1/2 Acute Graft versus Host Disease Study (BALANCE)

November 13, 2019
·
11 min read
Policy

Zosano Pharma Announces Completion of Pre-NDA Meetings with FDA for Qtrypta™Zosano plans to submit NDA for Qtrypta in December 2019

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, announced that it has received minutes from pre- New Drug Application meetings with the Food and Drug Administration for the acute treatment of migraine for Qtrypta.

November 13, 2019
·
3 min read
Business

Amedisys to Present at the 2019 Jefferies London Healthcare Conference

Amedisys, Inc. announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 Jefferies London Healthcare Conference in London, England on Wednesday, November 20, 2019.

November 13, 2019
·
1 min read
Business

China Biologic Reports Financial Results for the Third Quarter of 2019

China Biologic Products Holdings, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, announced its unaudited financial results for the third quarter of 2019.

November 13, 2019
·
8 min read
Deals

Eton Pharmaceuticals Announces $10 Million Debt Facility with SWK Holdings

Eton Pharmaceuticals, Inc announced it has entered into a $10 million debt facility with SWK Holdings Corporation.

November 13, 2019
·
3 min read
Pharm Country

Trevi Therapeutics to Present at Stifel Healthcare Conference

Trevi Therapeutics, Inc. announced that management will present a Company overview, as well as host investor meetings, at the Stifel 2019 Healthcare Conference

November 13, 2019
·
2 min read
Biotech Bay

Through Apple Heart Study, Stanford Medicine Researchers Show Wearable Technology Can Help Detect Atrial Fibrillation

Study shows that Apple Watch app can identify heart rhythm irregularities, which can help catch atrial fibrillation.

November 13, 2019
·
5 min read
Business

Boehringer Ingelheim and Lilly announce outcome of FDA Advisory Committee meeting for empagliflozin 2.5 mg as adjunct to insulin for adults with type 1 diabetes

The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee voted 14 to 2 that the benefits of empagliflozin 2.5 mg do not outweigh the risks to support approval as an adjunct to insulin for adults with type 1 diabetes.

November 13, 2019
·
7 min read
Biotech Bay

Nektar to Webcast Presentation at Jefferies 2019 London Healthcare Conference

Nektar Therapeutics’ senior management is scheduled to present at the upcoming Jefferies 2019 Healthcare Conference in London on Wednesday, November 20, 2019 at 4:00 p.m. Greenwich Mean Time.

November 13, 2019
·
1 min read
Pharm Country

Medidata NEXT NYC 2019 Delivers Roadmap for Future Innovation in Clinical Research

Medidata, a global leader in creating end-to-end solutions that support the entire clinical trial process, and part of Dassault Systèmes, concluded its most successful NEXT NYC event to date.

November 13, 2019
·
4 min read